Unifocal Langerhans-cell histiocytosis is a rare disorder characterized by the proliferation of Langerhans cells, which are a type of dendritic cell involved in immune response. This condition typically presents as a solitary bone lesion, often affecting children and young adults. Accurate coding with ICD-10 Code C96.6 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this condition.
ICD-10 Code C96.6 specifically denotes Unifocal Langerhans-cell histiocytosis, a localized form of histiocytosis that primarily affects bone. This code should be used when documenting cases of solitary lesions, typically in pediatric patients, to facilitate accurate billing and clinical management. It is crucial for healthcare providers to utilize this code to ensure appropriate treatment and follow-up care.
Unifocal Langerhans-cell histiocytosis is caused by an abnormal proliferation of Langerhans cells, leading to localized lesions that can cause pain and bone destruction. Early diagnosis and treatment are critical to prevent complications and ensure optimal patient outcomes.
In SOAP notes, ICD-10 Code C96.6 is utilized to document the diagnosis of Unifocal Langerhans-cell histiocytosis, aiding in the assessment of symptoms, clinical findings, and treatment plans. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient management.
ICD-10 Code C96.6 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Unifocal Langerhans-cell histiocytosis. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
Management of Unifocal Langerhans-cell histiocytosis may require hospitalization for severe cases. Treatment typically involves surgical intervention or corticosteroid therapy.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C96.6 is critical for billing in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 99213 | Established patient office visit, moderate complexity. |
| 20610 | Arthrocentesis, aspiration, and/or injection into a major joint or bursa. |
| 11100 | Biopsy of skin, subcutaneous tissue, or mucous membrane. |
Common Questions About Using ICD-10 Code C96.6 for Unifocal Langerhans-cell histiocytosis
What are the common symptoms of Unifocal Langerhans-cell histiocytosis?
Common symptoms include localized bone pain, swelling at the lesion site, and potential pathological fractures. Patients may also report tenderness in the affected area.
How is Unifocal Langerhans-cell histiocytosis diagnosed?
Diagnosis typically involves clinical evaluation, imaging studies such as X-rays or MRI, and sometimes biopsy to confirm the presence of Langerhans cells.
What treatment options are available for this condition?
Treatment may include surgical intervention to remove the lesion, corticosteroid therapy to reduce inflammation, and supportive care to manage symptoms.
Is Unifocal Langerhans-cell histiocytosis contagious?
No, Unifocal Langerhans-cell histiocytosis is not contagious. It is a neoplastic condition related to the proliferation of Langerhans cells and does not spread from person to person.
Clinical Notes
SOAP notes
DAP notes
AI medical notes